Argentina to start Covid vaccination of children aged 3-11 by end of 2021

The Argentine National Administration of Drugs, Food and Medical Technology (ANMAT) has authorised the use of the Chinese Sinopharm vaccine against COVID-19 for children aged 3-11 years, Health Minister Carla Vizzotti said, adding that the campaign will start by the end of the year.

"ANMAT has confirmed that we can use Sinopharm [vaccine] for children aged 3-11 years ... Argentina will finish 2021 with the full coverage and protection of people aged over 3 years," Vizzotti said at a press conference on late Friday.

The minister added that there were from 5.5 to 6 million children of this age in Argentina.

Argentina has confirmed more than 5.25 million COVID-19 cases so far, with over 115,000 fatalities.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel